Cambrian BioPharma Inc, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 46,125 shares at $4.99 ($236K) on 2022-01-14, disclosed to the SEC on 2022-01-18.
Open-market purchase of $236k SNSE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.13 | 19,953 | $102K | 43.4% |
| 2 | $5.13 | 19,953 | $102K | 43.4% |
| 3 | $4.99 | 6,219 | $31K | 13.2% |
| Total | $5.11 avg | 46,125 | $236K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |